North Star Investment Management Corp. Clovis Oncology, Inc. Transaction History

North Star Investment Management Corp.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 03, 2019	BUY	$3.93 - $15.35 $393 - $1,535	100 New	100 $0
Q2 2019 Jul 15, 2019	SELL	$12.81 - $25.67 $1,281 - $2,567	-100 Closed	0 $0
Q1 2019 Apr 10, 2019	BUY	$17.66 - $30.28 $1,766 - $3,028	100 New	100 $2,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

Stay updated on North Star Investment Management Corp. with notifications on news.